Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Puma Biotechnology
Puma Biotechnology Third Quarter 2022 Earnings: Beats Expectations
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology
Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Surging
Former Puma Biotechnology Executive Sentenced to More than Two Years in Prison for Insider Trading | BioSpace
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
